Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

China Active Pharmaceutical Ingredients Market Research Report 2017

  • QYR1002046
  • 121 Pages
  • February 2017
  • Pharmaceuticals
Download Sample    Get Discount   
 
Notes:

Sales, means the sales volume of Active Pharmaceutical Ingredients

Revenue, means the sales value of Active Pharmaceutical Ingredients

This report studies Active Pharmaceutical Ingredients in China market, focuses on the top players in China market, with capacity, production, price, revenue and market share for each manufacturer, covering

Pfizer

Novartis International

Sanofi

Boehringer Ingelheim

Bristol-Myers Squibb

Teva Pharmaceutical

Eli Lilly and Company

GlaxoSmithKline

Merck & Co

AbbVie

Johnson & Johnson

Bayer

Sun Pharmaceutical Industries

DSM

Hisun Pharmacy

Huahai Pharmaceutical

North China Pharmaceutical Group

Shandong Lukang Pharmaceutical

Haerbin Pharmaceutical Group

Shandong Xinhua Pharmaceutical

Jiangsu Hengrui Medicine

Lonza Group

Aurobindo Pharma

Lupin

Biocon

Market Segment by Regions (provinces), covering

South China

East China

Southwest China

Northeast China

North China

Central China

Northwest China

Split by product Type, with production, revenue, price, market share and growth rate of each type, can be divided into

Synthetic APIs

Biotech APIs

Split by Application, this report focuses on consumption, market share and growth rate of Active Pharmaceutical Ingredients in each application, can be divided into

Oncology

Diabetes

Cardiovascular Disease

CNS and Neurological Disorders

Endocrinology

Other

Table of Contents

China Active Pharmaceutical Ingredients Market Research Report 2017

1 Active Pharmaceutical Ingredients Market Overview

1.1 Product Overview and Scope of Active Pharmaceutical Ingredients

1.2 Active Pharmaceutical Ingredients Segment by Type

1.2.1 China Production Market Share of Active Pharmaceutical Ingredients Type in 2015

1.2.2 Synthetic APIs

1.2.3 Biotech APIs

1.3 Applications of Active Pharmaceutical Ingredients

1.3.1 Active Pharmaceutical Ingredients Consumption Market Share by Application in 2015

1.3.2 Oncology

1.3.3 Diabetes

1.3.4 Cardiovascular Disease

1.3.5 CNS and Neurological Disorders

1.3.6 Endocrinology

1.3.7 Other

1.4 China Market Size (Value) of Active Pharmaceutical Ingredients (2012-2022)

1.5 China Active Pharmaceutical Ingredients Status and Outlook

1.6 Government Policies

2 China Active Pharmaceutical Ingredients Market Competition by Manufacturers

2.1 China Active Pharmaceutical Ingredients Capacity, Production and Share by Manufacturers (2015 and 2016)

2.2 China Active Pharmaceutical Ingredients Revenue and Share by Manufacturers (2015 and 2016)

2.3 China Active Pharmaceutical Ingredients Average Price by Manufacturers (2015 and 2016)

2.4 Manufacturers Active Pharmaceutical Ingredients Manufacturing Base Distribution, Sales Area, Product Type

2.5 Active Pharmaceutical Ingredients Market Competitive Situation and Trends

2.5.1 Active Pharmaceutical Ingredients Market Concentration Rate

2.5.2 Active Pharmaceutical Ingredients Market Share of Top 3 and Top 5 Manufacturers

3 China Active Pharmaceutical Ingredients Manufacturers Profiles/Analysis

3.1 Pfizer

3.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

3.1.2 Active Pharmaceutical Ingredients Product Type, Application and Specification

3.1.2.1 Synthetic APIs

3.1.2.2 Biotech APIs

3.1.3 Pfizer Active Pharmaceutical Ingredients Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)

3.1.4 Main Business/Business Overview

3.2 Novartis International

3.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

3.2.2 Active Pharmaceutical Ingredients Product Type, Application and Specification

3.2.2.1 Synthetic APIs

3.2.2.2 Biotech APIs

3.2.3 Novartis International 121 Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)

3.2.4 Main Business/Business Overview

3.3 Sanofi

3.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

3.3.2 Active Pharmaceutical Ingredients Product Type, Application and Specification

3.3.2.1 Synthetic APIs

3.3.2.2 Biotech APIs

3.3.3 Sanofi 127 Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)

3.3.4 Main Business/Business Overview

3.4 Boehringer Ingelheim

3.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

3.4.2 Active Pharmaceutical Ingredients Product Type, Application and Specification

3.4.2.1 Synthetic APIs

3.4.2.2 Biotech APIs

3.4.3 Boehringer Ingelheim Jan Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)

3.4.4 Main Business/Business Overview

3.5 Bristol-Myers Squibb

3.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

3.5.2 Active Pharmaceutical Ingredients Product Type, Application and Specification

3.5.2.1 Synthetic APIs

3.5.2.2 Biotech APIs

3.5.3 Bristol-Myers Squibb Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)

3.5.4 Main Business/Business Overview

3.6 Teva Pharmaceutical

3.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

3.6.2 Active Pharmaceutical Ingredients Product Type, Application and Specification

3.6.2.1 Synthetic APIs

3.6.2.2 Biotech APIs

3.6.3 Teva Pharmaceutical Million USD Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)

3.6.4 Main Business/Business Overview

3.7 Eli Lilly and Company

3.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

3.7.2 Active Pharmaceutical Ingredients Product Type, Application and Specification

3.7.2.1 Synthetic APIs

3.7.2.2 Biotech APIs

3.7.3 Eli Lilly and Company Pharmaceuticals Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)

3.7.4 Main Business/Business Overview

3.8 GlaxoSmithKline

3.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

3.8.2 Active Pharmaceutical Ingredients Product Type, Application and Specification

3.8.2.1 Synthetic APIs

3.8.2.2 Biotech APIs

3.8.3 GlaxoSmithKline Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)

3.8.4 Main Business/Business Overview

3.9 Merck & Co

3.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

3.9.2 Active Pharmaceutical Ingredients Product Type, Application and Specification

3.9.2.1 Synthetic APIs

3.9.2.2 Biotech APIs

3.9.3 Merck & Co Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)

3.9.4 Main Business/Business Overview

3.10 AbbVie

3.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

3.10.2 Active Pharmaceutical Ingredients Product Type, Application and Specification

3.10.2.1 Synthetic APIs

3.10.2.2 Biotech APIs

3.10.3 AbbVie Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)

3.10.4 Main Business/Business Overview

3.11 Johnson & Johnson

3.12 Bayer

3.13 Sun Pharmaceutical Industries

3.14 DSM

3.15 Hisun Pharmacy

3.16 Huahai Pharmaceutical

3.17 North China Pharmaceutical Group

3.18 Shandong Lukang Pharmaceutical

3.19 Haerbin Pharmaceutical Group

3.20 Shandong Xinhua Pharmaceutical

3.21 Jiangsu Hengrui Medicine

3.22 Lonza Group

3.23 Aurobindo Pharma

3.24 Lupin

3.25 Biocon

4 China Active Pharmaceutical Ingredients Capacity, Production, Revenue, Consumption, Export and Import (2012-2017)

4.1 China Active Pharmaceutical Ingredients Capacity, Production and Growth (2012-2017)

4.2 China Active Pharmaceutical Ingredients Revenue and Growth (2012-2017)

4.3 China Active Pharmaceutical Ingredients Production, Consumption, Export and Import (2012-2017)

5 China Active Pharmaceutical Ingredients Production, Revenue (Value), Price Trend by Type

5.1 China Active Pharmaceutical Ingredients Production and Market Share by Type (2012-2017)

5.2 China Active Pharmaceutical Ingredients Revenue and Market Share by Type (2012-2017)

5.3 China Active Pharmaceutical Ingredients Price by Type (2012-2017)

5.4 China Active Pharmaceutical Ingredients Production Growth by Type (2012-2017)

6 China Active Pharmaceutical Ingredients Market Analysis by Application

6.1 China Active Pharmaceutical Ingredients Consumption and Market Share by Application (2012-2017)

6.2 China Active Pharmaceutical Ingredients Consumption Growth Rate by Application (2012-2017)

6.3 Market Drivers and Opportunities

6.3.1 Potential Application

6.3.2 Emerging Markets/Countries

7 ChinaActive Pharmaceutical Ingredients Market Analysis by Regions (Provinces)

7.1 China Active Pharmaceutical Ingredients Production, Production Value and Price by Regions (Provinces)(2012-2017)

7.1.1 China Active Pharmaceutical Ingredients Production and Market Share by Regions (Provinces)(2012-2017)

7.1.2 China Active Pharmaceutical Ingredients Production Value and Market Share by Regions (Provinces)(2012-2017)

7.1.3 China Active Pharmaceutical Ingredients Sales Price by Regions (Provinces)(2012-2017)

7.2 China Active Pharmaceutical Ingredients Consumption by Regions (Provinces)(2012-2017)

7.3 China Active Pharmaceutical Ingredients Production, Consumption, Export and Import (2012-2017)

8 Active Pharmaceutical Ingredients Manufacturing Cost Analysis

8.1 Active Pharmaceutical Ingredients Key Raw Materials Analysis

8.1.1 Key Raw Materials

8.1.2 Price Trend of Key Raw Materials

8.1.3 Key Suppliers of Raw Materials

8.1.4 Market Concentration Rate of Raw Materials

8.2 Proportion of Manufacturing Cost Structure

8.2.1 Raw Materials

8.2.2 Labor Cost

8.2.3 Manufacturing Expenses

8.3 Manufacturing Process Analysis of Active Pharmaceutical Ingredients

9 Industrial Chain, Sourcing Strategy and Downstream Buyers

9.1 Active Pharmaceutical Ingredients Industrial Chain Analysis

9.2 Upstream Raw Materials Sourcing

9.3 Raw Materials Sources of Active Pharmaceutical Ingredients Major Manufacturers in 2015

9.4 Downstream Buyers

10 Marketing Strategy Analysis, Distributors/Traders

10.1 Marketing Channel

10.1.1 Direct Marketing

10.1.2 Indirect Marketing

10.1.3 Marketing Channel Development Trend

10.2 Market Positioning

10.2.1 Pricing Strategy

10.2.2 Brand Strategy

10.2.3 Target Client

10.3 Distributors/Traders List

11 Market Effect Factors Analysis

11.1 Technology Progress/Risk

11.1.1 Substitutes Threat

11.1.2 Technology Progress in Related Industry

11.2 Consumer Needs/Customer Preference Change

11.3 Economic/Political Environmental Change

12 China Active Pharmaceutical Ingredients Market Forecast (2017-2022)

12.1 China Active Pharmaceutical Ingredients Capacity, Production, Revenue Forecast (2017-2022)

12.2 China Active Pharmaceutical Ingredients Production, Import, Export and Consumption Forecast (2017-2022)

12.3 China Active Pharmaceutical Ingredients Production Forecast by Type (2017-2022)

12.4 China Active Pharmaceutical Ingredients Consumption Forecast by Application (2017-2022)

12.5 China Active Pharmaceutical Ingredients Production, Consumption, Import and Export Forecast by Regions (Provinces)(2017-2022)

12.5.1 China Active Pharmaceutical Ingredients Production Forecast by Regions (Provinces)(2017-2022)

12.5.2 China Active Pharmaceutical Ingredients Consumption Forecast by Regions (Provinces)(2017-2022)

12.5.3 China Active Pharmaceutical Ingredients Production, Consumption, Import and Export Forecast by Regions (Provinces)(2017-2022)

12.6 Active Pharmaceutical Ingredients Price Forecast (2017-2022)

13 Research Findings and Conclusion

14 Appendix

Methodology

Analyst Introduction

Data Source

List of Tables and Figures

Figure Picture of Active Pharmaceutical Ingredients

Figure China Production Market Share of Active Pharmaceutical Ingredients by Type in 2015

Figure Product Picture of Synthetic APIs

Table Major Manufacturers of Synthetic APIs

Figure Product Picture of Biotech APIs

Table Major Manufacturers of Biotech APIs

Table Active Pharmaceutical Ingredients Consumption Market Share by Application in 2015

Figure Oncology Examples

Figure Diabetes Examples

Figure Cardiovascular Disease Examples

Figure CNS and Neurological Disorders Examples

Figure Endocrinology Examples

Figure Other Examples

Figure China Active Pharmaceutical Ingredients Revenue (Million USD) and Growth Rate (2012-2022)

Table China Active Pharmaceutical Ingredients Capacity of Key Manufacturers (2015 and 2016)

Table China Active Pharmaceutical Ingredients Capacity Market Share of Key Manufacturers (2015 and 2016)

Figure China Active Pharmaceutical Ingredients Capacity of Key Manufacturers in 2015

Figure China Active Pharmaceutical Ingredients Capacity of Key Manufacturers in 2016

Table China Active Pharmaceutical Ingredients Production of Key Manufacturers (2015 and 2016)

Table China Active Pharmaceutical Ingredients Production Share by Manufacturers (2015 and 2016)

Figure 2015 Active Pharmaceutical Ingredients Production Share by Manufacturers

Figure 2016 Active Pharmaceutical Ingredients Production Share by Manufacturers

Table China Active Pharmaceutical Ingredients Revenue (Million USD) by Manufacturers (2015 and 2016)

Table China Active Pharmaceutical Ingredients Revenue Share by Manufacturers (2015 and 2016)

Table 2015 China Active Pharmaceutical Ingredients Revenue Share by Manufacturers

Table 2016 China Active Pharmaceutical Ingredients Revenue Share by Manufacturers

Table China Market Active Pharmaceutical Ingredients Average Price of Key Manufacturers (2015 and 2016)

Figure China Market Active Pharmaceutical Ingredients Average Price of Key Manufacturers in 2015

Table Manufacturers Active Pharmaceutical Ingredients Manufacturing Base Distribution and Sales Area

Table Manufacturers Active Pharmaceutical Ingredients Product Type

Figure Active Pharmaceutical Ingredients Market Share of Top 3 Manufacturers

Figure Active Pharmaceutical Ingredients Market Share of Top 5 Manufacturers

Table Pfizer Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Pfizer Active Pharmaceutical Ingredients Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

Figure Pfizer Active Pharmaceutical Ingredients Market Share (2012-2017)

Table Novartis International Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Novartis International Active Pharmaceutical Ingredients Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

Figure Novartis International Active Pharmaceutical Ingredients Market Share (2012-2017)

Table Sanofi Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Sanofi Active Pharmaceutical Ingredients Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

Figure Sanofi Active Pharmaceutical Ingredients Market Share (2012-2017)

Table Boehringer Ingelheim Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Boehringer Ingelheim Active Pharmaceutical Ingredients Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

Figure Boehringer Ingelheim Active Pharmaceutical Ingredients Market Share (2012-2017)

Table Bristol-Myers Squibb Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Bristol-Myers Squibb Active Pharmaceutical Ingredients Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

Figure Bristol-Myers Squibb Active Pharmaceutical Ingredients Market Share (2012-2017)

Table Teva Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Teva Pharmaceutical Active Pharmaceutical Ingredients Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

Figure Teva Pharmaceutical Active Pharmaceutical Ingredients Market Share (2012-2017)

Table Eli Lilly and Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Eli Lilly and Company Active Pharmaceutical Ingredients Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

Figure Eli Lilly and Company Active Pharmaceutical Ingredients Market Share (2012-2017)

Table GlaxoSmithKline Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table GlaxoSmithKline Active Pharmaceutical Ingredients Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

Figure GlaxoSmithKline Active Pharmaceutical Ingredients Market Share (2012-2017)

Table Merck & Co Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Merck & Co Active Pharmaceutical Ingredients Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

Figure Merck & Co Active Pharmaceutical Ingredients Market Share (2012-2017)

Table AbbVie Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table AbbVie Active Pharmaceutical Ingredients Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

Figure AbbVie Active Pharmaceutical Ingredients Market Share (2012-2017)

Table Johnson & Johnson Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Bayer Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Sun Pharmaceutical Industries Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table DSM Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Hisun Pharmacy Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Huahai Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table North China Pharmaceutical Group Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Shandong Lukang Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Haerbin Pharmaceutical Group Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Shandong Xinhua Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Jiangsu Hengrui Medicine Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Lonza Group Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Aurobindo Pharma Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Lupin Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Biocon Basic Information, Manufacturing Base, Sales Area and Its Competitors

Figure China Active Pharmaceutical Ingredients Capacity, Production and Growth (2012-2017)

Figure China Active Pharmaceutical Ingredients Revenue (Million USD) and Growth (2012-2017)

Table China Active Pharmaceutical Ingredients Production, Consumption, Export and Import (2012-2017)

Table China Active Pharmaceutical Ingredients Production by Type (2012-2017)

Table China Active Pharmaceutical Ingredients Production Share by Type (2012-2017)

Figure Production Market Share of Active Pharmaceutical Ingredients by Type (2012-2017)

Figure 2015 Production Market Share of Active Pharmaceutical Ingredients by Type

Table China Active Pharmaceutical Ingredients Revenue by Type (2012-2017)

Table China Active Pharmaceutical Ingredients Revenue Share by Type (2012-2017)

Figure Production Revenue Share of Active Pharmaceutical Ingredients by Type (2012-2017)

Figure 2015 Revenue Market Share of Active Pharmaceutical Ingredients by Type

Table China Active Pharmaceutical Ingredients Price by Type (2012-2017)

Figure China Active Pharmaceutical Ingredients Production Growth by Type (2012-2017)

Table China Active Pharmaceutical Ingredients Consumption by Application (2012-2017)

Table China Active Pharmaceutical Ingredients Consumption Market Share by Application (2012-2017)

Figure China Active Pharmaceutical Ingredients Consumption Market Share by Application in 2015

Table China Active Pharmaceutical Ingredients Consumption Growth Rate by Application (2012-2017)

Figure China Active Pharmaceutical Ingredients Consumption Growth Rate by Application (2012-2017)

Table China Active Pharmaceutical Ingredients Production by Regions (Provinces)(2012-2017)

Table China Active Pharmaceutical Ingredients Production Market Share by Regions (Provinces)(2012-2017)

Table China Active Pharmaceutical Ingredients Production Value by Regions (Provinces)(2012-2017)

Table China Active Pharmaceutical Ingredients Production Value Market Share by Regions (Provinces)(2012-2017)

Table China Active Pharmaceutical Ingredients Sales Price by Regions (Provinces)(2012-2017)

Table China Active Pharmaceutical Ingredients Consumption by Regions (Provinces)(2012-2017)

Table China Active Pharmaceutical Ingredients Consumption Market Share by Regions (Provinces)(2012-2017)

Table China Active Pharmaceutical Ingredients Production, Consumption, Export and Import (2012-2017)

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Active Pharmaceutical Ingredients

Figure Manufacturing Process Analysis of Active Pharmaceutical Ingredients

Figure Active Pharmaceutical Ingredients Industrial Chain Analysis

Table Raw Materials Sources of Active Pharmaceutical Ingredients Major Manufacturers in 2015

Table Major Buyers of Active Pharmaceutical Ingredients

Table Distributors/Traders List

Figure China Active Pharmaceutical Ingredients Capacity, Production and Growth Rate Forecast (2017-2022)

Figure China Active Pharmaceutical Ingredients Revenue and Growth Rate Forecast (2017-2022)

Table China Active Pharmaceutical Ingredients Production, Import, Export and Consumption Forecast (2017-2022)

Table China Active Pharmaceutical Ingredients Production Forecast by Type (2017-2022)

Table China Active Pharmaceutical Ingredients Consumption Forecast by Application (2017-2022)

Table China Active Pharmaceutical Ingredients Production Forecast by Regions (Provinces)(2017-2022)

Table China Active Pharmaceutical Ingredients Consumption Forecast by Regions (Provinces)(2017-2022)

Table China Active Pharmaceutical Ingredients Production, Consumption, Import and Export Forecast by Regions (Provinces)(2017-2022)

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

Protein Therapeutics Market by Product (Monoclonal Antibodies, Insulin, Fusion Protein, Erythropoietin, Interferon, Human Growth Hormone, and Follicle Stimulating Hormone) and Application (Metabolic Disorders, Immunologic Disorders, Hematological Disorders, Cancer, Hormonal Disorders, Genetic Disorders, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023

Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...

  • Publish Date: November 14, 2017
  • $5370
Global Cord Blood Banking Services (Stem Cell) Market, Size, Share, Trends, Forecast, Global Analysis, Research, Report, Segmentation, and Future Demand, 2012 - 2020

Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...

  • Publish Date: July 20, 2017
  • $5370